Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATCC ATCC PDM-110 patient-derived pancreatic adenocarcinoma organoid model (human, BSL-1)
Supplier: ATCC HCMBROD0015C25
ATCC PDM-110 is a patient-derived next-generation organoid model produced via the Human Cancer Models Initiative (HCMI) from primary pancreatic adenocarcinoma tissue. It is intended for 3D cell culture and pharmacological screening applications in cancer research and basic research.
- Derived from primary pancreatic adenocarcinoma tissue, human origin.
- Suitable for 3D cell culture, cancer research, and compound screening.
- Biosafety level 1 for use under standard laboratory conditions.
- Supplied with cells per vial ≥ 1.0 x 10^6.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?